These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32689578)

  • 41. Meta-analysis of the efficacy and safety of tirofiban in patients with acute ischaemic stroke undergoing mechanical thrombectomy.
    Liu C; Yang X; Liu M; Wang J; Li G
    Clin Neurol Neurosurg; 2023 May; 228():107702. PubMed ID: 37058772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke.
    Lee JI; Gliem M; Gerdes G; Turowski B; Kaschner M; Kraus B; Hartung HP; Jander S
    PLoS One; 2017; 12(12):e0190218. PubMed ID: 29281734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous Thrombolysis for Ischemic Stroke Patients on Dual Antiplatelets.
    Tsivgoulis G; Katsanos AH; Mavridis D; Gdovinova Z; Karliński M; Macleod MJ; Strbian D; Ahmed N
    Ann Neurol; 2018 Jul; 84(1):89-97. PubMed ID: 30048012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice].
    Haerten K; Krabbe C; Raiber M
    Dtsch Med Wochenschr; 2004 Mar; 129(12):607-10. PubMed ID: 15011129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and Outcome of Endovascular Treatment for Minor Ischemic Stroke: Results From the Multicenter Clinical Registry of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands.
    Goldhoorn RB; Mulder MJHL; Jansen IGH; van Zwam WH; Staals J; van der Lugt A; Dippel DWJ; Lingsma HF; Vos JA; Boiten J; van den Wijngaard IR; Majoie CBLM; Roos YBWEM; van Oostenbrugge RJ;
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):542-549. PubMed ID: 30527790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deterioration.
    Du Y; Li Y; Duan Z; Ma C; Wang H; Liu R; Li S; Lian Y
    J Clin Pharm Ther; 2022 Dec; 47(12):2350-2359. PubMed ID: 36461632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
    Dyke CM
    Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. To Load or Not to Load? Aspirin Loading in Acute Ischemic Stroke: A Study of Clinical Outcomes.
    Su TH; Chan YL; Lee JD; Lee M; Lin LC; Wen YW; Lee TH
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2439-47. PubMed ID: 27388708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors affecting the outcomes of tirofiban after endovascular treatment in acute ischemic stroke: Experience from a single center.
    Wang Y; Ma H; Zhang Q; Jin F; Xu Y; Ma Q; Ji X
    CNS Neurosci Ther; 2023 Mar; 29(3):957-967. PubMed ID: 36601660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke.
    Lan L; Rong X; Shen Q; Gong H; Li X; Wang H; Li M; Pan J; Zhang X; Peng Y
    Int J Neurosci; 2020 Sep; 130(9):857-864. PubMed ID: 31928267
    [No Abstract]   [Full Text] [Related]  

  • 51. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1121-1132. PubMed ID: 32078096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perioperative Bridging With Glycoprotein IIb/IIIa Inhibitors Versus Cangrelor: Balancing Efficacy and Safety.
    Van Tuyl JS; Newsome AS; Hollis IB
    Ann Pharmacother; 2019 Jul; 53(7):726-737. PubMed ID: 30646761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical analysis for efficacy of tirofiban combined with ozagrel in the treatment of progressive cerebral infarction patients out of thrombolytic therapy time window.
    Zhang H; Zheng L
    Clinics (Sao Paulo); 2021; 76():e2728. PubMed ID: 34133479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of prophylactic tirofiban infusion for acute intracranial intraprocedural stent thrombosis.
    Sun L; Zhang J; Song Y; Zhao W; Zheng M; Zhang J; Yin H; Wang W; Meng Y; Han J
    Sci Rep; 2021 Oct; 11(1):21326. PubMed ID: 34716365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
    Januzzi JL; Snapinn SM; DiBattiste PM; Jang IK; Theroux P
    Circulation; 2002 May; 105(20):2361-6. PubMed ID: 12021221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients with moderate to severe strokes (NIHSS score >10) undergoing urgent carotid interventions within 48 hours have worse functional outcomes.
    Mihindu E; Mohammed A; Smith T; Brinster C; Sternbergh WC; Bazan HA
    J Vasc Surg; 2019 May; 69(5):1471-1481. PubMed ID: 30635157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study.
    Liang Z; Zhang J; Huang S; Yang S; Xu L; Xiang W; Zhang M
    BMC Neurol; 2022 Jul; 22(1):280. PubMed ID: 35897006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis.
    Zhu X; Cao G
    Clin Appl Thromb Hemost; 2020; 26():1076029620942594. PubMed ID: 32727211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.